This inventor holds 1 USPTO granted patent. Top assignee: King Abdulaziz University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Majed Abdullah A Alharbi: Innovator in Cancer Treatment
Introduction
Majed Abdullah A Alharbi is a prominent inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds.
Latest Patents
Alharbi holds a patent for "Arylacetamides as AMP-activated protein kinase inhibitors and their use for treatment of breast cancer." This patent describes therapeutic compounds containing an arylacetamide core with a pending N-benzyl group. The invention also includes pharmaceutical compositions that incorporate these therapeutic compounds and outlines a method for inhibiting AMP-activated kinase (AMPK). These compounds are intended for treating breast and pancreatic cancer.
Career Highlights
Alharbi is affiliated with King Abdulaziz University, where he continues to advance his research in the medical field. His work focuses on developing innovative solutions for complex health issues, particularly in oncology.
Collaborations
He collaborates with notable colleagues, including Abdelsattar Mansour Omar and Mohammad Imran Khan, to further enhance the impact of his research.
Conclusion
Majed Abdullah A Alharbi is a dedicated inventor whose work in cancer treatment exemplifies the importance of innovation in medicine. His contributions are paving the way for new therapeutic options for patients battling cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile